Concepedia

In Vitro Antifungal Susceptibilities of<i>Sporothrix schenckii</i>in Two Growth Phases

Luciana Trilles, Belkys Fernández-Torres, Márcia dos Santos Lazéra, Bodo Wanke, Armando de Oliveira Schubach, Rodrigo de Almeida Paes, Isabel Inza, Josep Guarro

Antimicrobial Agents and Chemotherapy · 2005 · 45 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and the temperature of incubation (30 or 35 degrees C) exerted a significant influence on the MICs.

References

14

Practice Guidelines for the Management of Patients with Sporotrichosis

Carol A. Kauffman, Rana Hajjeh, Stanley W. Chapman · Clinical Infectious Diseases · 2000 · 226 citations · Full text

, , +16

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi

Elizabeth M. Johnson, Adrien Székely, David W. Warnock · Journal of Antimicrobial Chemotherapy · 1998 · 216 citations · Full text

, , +15

In Vitro Antifungal Activity of Micafungin (FK463) against Dimorphic Fungi: Comparison of Yeast-Like and Mycelial Forms

Toru Nakai, Jun Uno, Fumiaki Ikeda et al. · Antimicrobial Agents and Chemotherapy · 2003 · 155 citations · Full text

, , +15

Treatment of sporotrichosis with itraconazole

Patricia K. Sharkey-Mathis, Carol A. Kauffman, John R. Graybill et al. · The American Journal of Medicine · 1993 · 153 citations · Full text

, , +4

A Pan-American 5-Year Study of Fluconazole Therapy for Deep Mycoses in the Immunocompetent Host

Manuel Concha Díaz, Ricardo Negroni, F. Montero-Gei et al. · Clinical Infectious Diseases · 1992 · 138 citations

, , +17